Co-localization suggested that the decreased ADIPOQ levels in the CM group are related to its reduced anti-inflammatory effects (Figure 6), which could exacerbate mastitis, supporting the conclusion that ADIPOQ mitigates the harmful effects of pathogens on epithelial cells by activating anti-inflammatory pathways [48]. This evidence concerns the gene ADIPOQ and mastitis.